Armata Pharmaceuticals Financials - Benzinga

Armata Pharmaceuticals Inc

ARMPAMEX

Trade with Public

Trade with Public

$5.51

0.142.61%

At close: Aug 31, 5:00 PM EST

$5.50

-0.01-0.18%

After Hours: 8:37 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Armata Pharmaceuticals Financials

Armata Pharmaceuticals (ARMP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Armata Pharmaceuticals Q2 EPS $(0.27) Beats $(0.45) Estimate, Sales $2.510M Beat $420.000K Estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.45) by 38.64 percent. This is a 40 percent increase over losses of $(0.45) per share

Benzinga Newsdesk

PRO
Armata Pharmaceuticals Q1 EPS $(3.16) Misses $(0.38) Estimate, Sales $789.000K Up From $491.000K YoY

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(3.16) per share which missed the analyst consensus estimate of $(0.38) by 731.58 percent. This is a 1480 percent decrease over losses of $(0.20) per share

Benzinga Newsdesk

PRO
Armata Pharmaceuticals Q4 EPS $(3.43) Misses $(0.28) Estimate, Sales $1.085M Beat $750.000K Estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(3.43) per share which missed the analyst consensus estimate of $(0.28) by 1125 percent. This is a 1391.3 percent decrease over losses of $(0.23) per share

Benzinga Newsdesk

PRO
Armata Pharmaceuticals Q3 EPS $(0.74) Misses $(0.42) Estimate, Sales $1.159M Miss $1.380M Estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.42) by 76.19 percent. This is a 393.33 percent decrease over losses of $(0.15) per

Benzinga Newsdesk

PRO
Armata Pharmaceuticals Q2 EPS $(0.45) Misses $(0.39) Estimate, Sales $2.169M Beat $1.380M Estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 80 percent decrease over losses of $(0.25) per share

Benzinga Newsdesk

PRO
Armata Pharmaceuticals Q1 EPS $(0.20) Beats $(0.38) Estimate, Sales $491.00K Miss $1.38M Estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.38) by 47.37 percent. This is a 71.01 percent increase over losses of $(0.69) per share

Benzinga Newsdesk